This person has an effected PI3Kinase, or MAP pathway. We only have drugs for a few of the major mutations so once the cancer mutates to avoid drugging, patients are often out of luck.
Yeah, patients relapsing into cancer usually do not have much alternatives. Combination therapies often help since they can attach several pathways at once, but combo therapies are usually limited to 2 compounds at the same time.
Another huge problem is linked to medical practice. So many doctors treating cancer patients are just NOT aware of the latest studies and developments in terms of Standards of Care. If you have a cancer, the most relevant factor is the necessarily the drug you take but who's treating you and how much he knows about your condition.
Helping doctors make decisions may be another area for disruption, where Software may help.
Comments
Yeah, patients relapsing into cancer usually do not have much alternatives. Combination therapies often help since they can attach several pathways at once, but combo therapies are usually limited to 2 compounds at the same time.
Another huge problem is linked to medical practice. So many doctors treating cancer patients are just NOT aware of the latest studies and developments in terms of Standards of Care. If you have a cancer, the most relevant factor is the necessarily the drug you take but who's treating you and how much he knows about your condition.
Helping doctors make decisions may be another area for disruption, where Software may help.